Chemours Q4 net loss widens to $47M; Q1 sales forecast up 3–5%
Chemours posted a Q4 net loss of $47 million, or $0.31 per share, on net sales of $1.329 billion, with adjusted EBITDA down 24% to $128 million due to lower volumes and pricing pressures. The company sees Q1 net sales rising 3–5% and projects 2026 adjusted EBITDA of $800–900 million.
1. Q4 Financial Results
Chemours reported a fourth-quarter net loss of $47 million, or $0.31 per share, compared with a $11 million loss a year earlier, on net sales of $1.329 billion, in line with estimates. Adjusted EBITDA declined 24% year over year to $128 million, driven by lower volumes, weaker pricing and a significant non-cash inventory charge.
2. Segment Performance
The Titanium Technologies division recorded $561 million in revenues, down 11% year over year on a 6% price drop and 4% volume decline. Thermal & Specialized Solutions revenues climbed 14% to $444 million on higher refrigerant prices and volume gains, while Advanced Performance Materials fell 4% to $312 million due to an 8% volume decrease offset by a 3% price increase.
3. Cash Flow and Balance Sheet
Operating cash flow was $137 million, roughly flat sequentially, while capital expenditures dropped to $45 million from $109 million year ago. Cash and equivalents stood at $670 million, a 6% year-over-year decline, reflecting lower capex in key segments.
4. Outlook and Guidance
The company forecasts Q1 net sales growth of 3–5% and adjusted EBITDA of $120–150 million, with full-year 2026 sales growth of 3–5% and adjusted EBITDA of $800–900 million. Capital expenditures are expected at $275–325 million for 2026 with free cash flow conversion above 25%.